Skip to main content

Find Clinical Trials

Home
Conditions
Nodal Marginal Zone B-cell Lymphoma

Clinical trial condition

Nodal Marginal Zone B-cell Lymphoma

Explore clinical trials studying Nodal Marginal Zone B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

83 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Nodal Marginal Zone B-cell Lymphoma trial results

Completed

Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00068315

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations: Mercy Medical Center Canton, Ohio, United States

Case Western Reserve University Cleveland, Ohio, United States

Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Southwest General Health Center Ireland Cancer Center Middleburg Heights, Ohio, United States

View Trial Details

Completed

3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00293345

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +107 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00026182

Conditions: Chronic Disease, Disease Attributes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +26 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Completed

Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer

NCT00010192

Conditions: B-cell Adult Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +82 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

NCT00058227

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +71 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia

NCT00017472

Conditions: Chronic Disease, Disease Attributes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +34 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction

NCT00054483

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blood Protein Disorders, +74 more
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

NCT00348985

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +109 more
Locations: University of Colorado Denver, Colorado, United States

View Trial Details

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

NCT00004241

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +105 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

NCT00025415

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details